🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 10 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/12/2021 73,27 74,50 70,74 70,83 -4,23% 5,13% 507.900
08/12/2021 72,32 74,77 71,05 73,96 +3,20% 5,14% 660.800
07/12/2021 67,63 72,82 67,34 71,67 +8,87% 8,10% 796.600
06/12/2021 67,26 67,50 63,45 65,83 -2,47% 6,02% 775.100
03/12/2021 70,17 70,41 66,77 67,50 -3,14% 5,19% 715.700
02/12/2021 67,42 69,85 66,54 69,69 +4,01% 4,91% 547.000
01/12/2021 70,65 71,45 66,94 67,00 -4,35% 6,38% 699.500
30/11/2021 70,99 72,95 67,20 70,05 -1,57% 8,10% 830.000
29/11/2021 73,57 74,32 70,71 71,17 -1,18% 4,91% 580.300
26/11/2021 72,39 73,68 69,70 72,02 -2,73% 5,50% 650.600
24/11/2021 70,36 74,70 68,90 74,04 +4,44% 8,24% 590.600
23/11/2021 68,00 70,98 66,09 70,89 +2,32% 7,19% 985.600
22/11/2021 73,00 73,23 69,00 69,28 -2,57% 5,79% 782.000
19/11/2021 70,31 71,45 68,54 71,11 +0,51% 4,14% 786.700
18/11/2021 68,90 72,00 68,00 70,75 +11,00% 5,81% 1.877.900
17/11/2021 63,68 64,67 63,11 63,74 -0,30% 2,45% 490.900
16/11/2021 65,72 67,33 63,73 63,93 -2,99% 5,48% 752.700
15/11/2021 73,38 74,01 65,54 65,90 -10,87% 11,54% 1.389.700
12/11/2021 76,50 76,92 72,32 73,94 -2,43% 6,01% 537.400
11/11/2021 77,45 78,18 75,47 75,78 -1,07% 3,50% 393.600
10/11/2021 81,16 82,33 76,07 76,60 -5,46% 7,71% 610.900
09/11/2021 83,00 84,83 80,65 81,02 -1,81% 5,04% 476.200
08/11/2021 81,83 83,88 81,47 82,51 +2,20% 2,95% 443.500
05/11/2021 81,85 83,22 79,65 80,73 -1,01% 4,37% 701.100
04/11/2021 80,03 82,07 77,06 81,55 +1,39% 6,26% 577.800
03/11/2021 77,15 81,36 76,50 80,43 +5,97% 6,30% 1.059.500
02/11/2021 70,99 75,97 70,01 75,90 +6,92% 8,40% 601.900
01/11/2021 63,97 71,01 63,61 70,99 +11,23% 11,57% 754.800
29/10/2021 64,77 65,37 63,35 63,82 -2,42% 3,12% 459.200
28/10/2021 64,51 65,56 63,68 65,40 +1,41% 2,91% 380.000